CSIMarket
 

Surrozen Inc   (SRZN)
Other Ticker:  
 

Surrozen Inc 's

Competitiveness


 

SRZN Sales vs. its Competitors Q3 2023







Revenue Growth Comparisons




Net Income Comparison




<<  SRZN Stock Performance Comparisons



*Market share is calculated based on total revenue.

  News about Surrozen Inc Contracts

Surrozen's Strategic Shift towards SZN-043 for Alcohol-Associated Hepatitis Signals Promising Research Focus

In a recent corporate update, biopharmaceutical company Surrozen announced a strategic prioritization of its clinical programs to concentrate on the development of SZN-043, a potential treatment for Alcohol-Associated Hepatitis (AAH). This decision marks a significant shift in Surrozen's research focus and holds considerable promise for addressing a pressing unmet medical need. This article aims to outline the pertinent facts gleaned from the announcement, shedding light on Surrozen's latest endeavors.Research Prioritization:Surrozen's recently announced strategic prioritization of clinical programs reflects a conscious choice to streamline efforts toward developing SZN-043 for AAH treatment. This disease, c...





Who are Surrozen Inc 's Competitors?





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com